ALZN (Alzamend Neuro, Inc.) is set to announce its Q4'25 results on July 01, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).
For Q4'25, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.67) USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q4'24Q1'25Q2'25Q3'25Q4'25 | |||||
| Revenue Reported————— | Revenue Estimate————— | Revenue Surprise | EPS Reported(2.36)(1.28)(0.30)(0.58) | EPS Estimate(2.70)(2.08)(0.30)(0.53)(0.67) | EPS Surprise+12.59%+38.46%+0.00%-9.43% |